The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23681 ↗At a glance
Journal article in Molecular Carcinogenesis, 2024. Written by Anna Han and 5 co-authors. Institution: Key Laboratory Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, China. Major MEDLINE topics: Stomach Neoplasms. Cited 4 times so far (Crossref); 25 references. Funded by: National Natural Science Foundation of China, Projects of Science and Technology Department of Jilin Province.
Abstract (original language)
Gastric cancer (GC) is a prevalent malignancy of the digestive system. Distant metastasis and chemotherapy resistance are the crucial obstacles to prognosis in GC. Recent research has discovered that the glucose‐6‐phosphatase catalytic subunit (G6PC) plays an important role in tumor malignant development. However, little evidence has highlighted its role in GC. Herein, through a comprehensive analysis including profiling of tissue samples and functional validation in vivo and in vitro, we identify G6PC as a crucial factor in GC tumorigenesis. Importantly, we found that the FOXO1/G6PC axis could accelerate GC cell proliferation, metastasis, and 5‐Fluorouracil (5‐FU) resistance by targeting the PI3K/AKT/mTOR signaling pathway, implicating that as a prospective therapeutic approach in GC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory Pathobiology (Yanbian University), State Ethnic Affairs Commission, Yanji, China.
- Center for Joint Surgery, Southwest Hospital, Army Medical University, Chongqing, China.
- Cancer Research Center, Yanbian University Medical College, Yanji, China.
Funding
- National Natural Science Foundation of China
- Projects of Science and Technology Department of Jilin Province
Cite
APA
Han, A., Liu, T., Du, P., Wang, M., Liu, J., & Chen, L. (2024). The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23681
Vancouver
Han A, Liu T, Du P, Wang M, Liu J, Chen L. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23681
BibTeX
@article{Han2024,
author = {Han, Anna and Liu, Taorui and Du, Pan and Wang, Mengying and Liu, Jiajing and Chen, Liyan},
title = {The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23681}
}
EUVIMED